IN8bio, Inc. (INAB)

IN8bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	27.09	11.12	21.28	18.18	37.02
Cash & Short-Term Investments	27.09	11.12	21.28	18.18	37.02
Cash Growth	143.63%	-47.75%	17.05%	-50.89%	105.74%
Other Current Assets	0.79	1.46	3.34	4.05	1.96
Total Current Assets	27.88	12.58	24.63	22.23	38.98
Net Property, Plant & Equipment	4.04	7.83	8.57	10.3	2.83
Other Long-Term Assets	0.37	0.54	0.51	0.51	0.41
Total Assets	32.28	20.94	33.71	33.04	42.22
Accounts Payable	0.31	0.39	0.92	2.09	0.4
Accrued Expenses	1.63	1.05	2.96	2.34	1.24
Current Portion of Leases	1.22	1.65	1.51	1.39	0.63
Total Current Liabilities	3.16	3.08	5.39	5.82	2.26
Long-Term Leases	1.56	3.38	3.38	4.49	1.78
Total Long-Term Liabilities	1.56	3.38	3.38	4.49	1.78
Total Liabilities	4.72	6.47	8.77	10.31	4.04
Common Stock	-	-	0	0	0
Additional Paid-in Capital	168.64	136.13	116.15	83.94	70.87
Retained Earnings	-141.1	-121.66	-91.22	-61.21	-32.69
Total Common Shareholders' Equity	27.56	14.48	24.94	22.73	38.18
Shareholders' Equity	27.56	14.48	24.94	22.73	38.18
Total Liabilities & Equity	32.28	20.94	33.71	33.04	42.22
Total Debt	2.78	5.03	4.89	5.87	2.41
Net Cash (Debt)	24.31	6.09	16.39	12.31	34.61
Net Cash Growth	299.18%	-62.84%	33.16%	-64.44%	94.23%
Net Cash Per Share	5.56	3.41	16.46	17.61	104.15
Book Value	27.56	14.48	24.94	22.73	38.18
Book Value Per Share	6.30	8.11	25.05	32.52	114.90
Tangible Book Value	27.56	14.48	24.94	22.73	38.18
Tangible Book Value Per Share	6.30	8.11	25.05	32.52	114.90

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q